Plans will continue covering GLP-1s, but coverage will become increasingly tied to: - Comorbidities - Outcomes - Adherence - Employer size - Total cost-of-care models The medications are too clinically effective and too culturally mainstream now, to disappear from benefit design altogether
With the same clinical significance, increased subcortical DA synthesis and release capacity are strongly associated with positive symptoms in schizophrenia patients, and increased subcortical synaptic DA content is predictive of a positive treatment response [74]
How to Talk to Your Doctor When you meet with a healthcare professional through a telehealth platform or in person, being prepared can help you get the best advice
[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Putchala M.C., Ramani P., Sherlin H.J., Premkumar P., Natesan A
Acknowledgements The authors wish to thank Mr
56 GirishV